382 related articles for article (PubMed ID: 29724992)
1. Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells.
Guo J; Zhao Y; Fei C; Zhao S; Zheng Q; Su J; Wu D; Li X; Chang C
Cell Death Dis; 2018 May; 9(5):512. PubMed ID: 29724992
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome.
Zhao Y; Wu D; Fei C; Guo J; Gu S; Zhu Y; Xu F; Zhang Z; Wu L; Li X; Chang C
Haematologica; 2015 Feb; 100(2):194-204. PubMed ID: 25361944
[TBL] [Abstract][Full Text] [Related]
3. Myeloma cell sensitivity to bortezomib is associated with Dicer1 expression.
Stuhler G; Nekova TS
Blood; 2014 Jul; 124(4):657-8. PubMed ID: 25061173
[No Abstract] [Full Text] [Related]
4. Metformin-mediated increase in DICER1 regulates microRNA expression and cellular senescence.
Noren Hooten N; Martin-Montalvo A; Dluzen DF; Zhang Y; Bernier M; Zonderman AB; Becker KG; Gorospe M; de Cabo R; Evans MK
Aging Cell; 2016 Jun; 15(3):572-81. PubMed ID: 26990999
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region.
Berenstein R; Blau O; Nogai A; Waechter M; Slonova E; Schmidt-Hieber M; Kunitz A; Pezzutto A; Doerken B; Blau IW
BMC Cancer; 2015 Feb; 15():68. PubMed ID: 25886144
[TBL] [Abstract][Full Text] [Related]
6. miR-29c-3p promotes senescence of human mesenchymal stem cells by targeting CNOT6 through p53-p21 and p16-pRB pathways.
Shang J; Yao Y; Fan X; Shangguan L; Li J; Liu H; Zhou Y
Biochim Biophys Acta; 2016 Apr; 1863(4):520-32. PubMed ID: 26792405
[TBL] [Abstract][Full Text] [Related]
7. Functional requirement of dicer1 and miR-17-5p in reactive astrocyte proliferation after spinal cord injury in the mouse.
Hong P; Jiang M; Li H
Glia; 2014 Dec; 62(12):2044-60. PubMed ID: 25043492
[TBL] [Abstract][Full Text] [Related]
8. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
[TBL] [Abstract][Full Text] [Related]
9. Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients.
Santamaría C; Muntión S; Rosón B; Blanco B; López-Villar O; Carrancio S; Sánchez-Guijo FM; Díez-Campelo M; Alvarez-Fernández S; Sarasquete ME; de las Rivas J; González M; San Miguel JF; Del Cañizo MC
Haematologica; 2012 Aug; 97(8):1218-24. PubMed ID: 22371183
[TBL] [Abstract][Full Text] [Related]
10. Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes.
Fei C; Zhao Y; Guo J; Gu S; Li X; Chang C
Eur J Haematol; 2014 Dec; 93(6):476-86. PubMed ID: 24889123
[TBL] [Abstract][Full Text] [Related]
11. Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P.
Liao CC; Ho MY; Liang SM; Liang CM
Autophagy; 2018; 14(12):2065-2082. PubMed ID: 30081720
[TBL] [Abstract][Full Text] [Related]
12. Role of Dicer1 in thyroid cell proliferation and differentiation.
Penha RCC; Sepe R; De Martino M; Esposito F; Pellecchia S; Raia M; Del Vecchio L; Decaussin-Petrucci M; De Vita G; Pinto LFR; Fusco A
Cell Cycle; 2017; 16(23):2282-2289. PubMed ID: 28933615
[TBL] [Abstract][Full Text] [Related]
13. DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.
Sun X; Tang SC; Xu C; Wang C; Qin S; Du N; Liu J; Zhang Y; Li X; Luo G; Zhou J; Xu F; Ren H
J Cell Mol Med; 2015 Jun; 19(6):1357-65. PubMed ID: 25702703
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of p21(Cip1/Waf1) enhances proliferation, the expression of stemness markers, and osteogenic potential in human mesenchymal stem cells.
Yew TL; Chiu FY; Tsai CC; Chen HL; Lee WP; Chen YJ; Chang MC; Hung SC
Aging Cell; 2011 Apr; 10(2):349-61. PubMed ID: 21342417
[TBL] [Abstract][Full Text] [Related]
15. A pH probe inhibits senescence in mesenchymal stem cells.
Wang L; Han X; Qu G; Su L; Zhao B; Miao J
Stem Cell Res Ther; 2018 Dec; 9(1):343. PubMed ID: 30526663
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.
Cipriani P; Di Benedetto P; Liakouli V; Del Papa B; Di Padova M; Di Ianni M; Marrelli A; Alesse E; Giacomelli R
Clin Exp Immunol; 2013 Aug; 173(2):195-206. PubMed ID: 23607751
[TBL] [Abstract][Full Text] [Related]
17. H2O2 accumulation mediates differentiation capacity alteration, but not proliferative decline, in senescent human fetal mesenchymal stem cells.
Ho PJ; Yen ML; Tang BC; Chen CT; Yen BL
Antioxid Redox Signal; 2013 May; 18(15):1895-905. PubMed ID: 23088254
[TBL] [Abstract][Full Text] [Related]
18. Aging-induced dysregulation of dicer1-dependent microRNA expression impairs angiogenic capacity of rat cerebromicrovascular endothelial cells.
Ungvari Z; Tucsek Z; Sosnowska D; Toth P; Gautam T; Podlutsky A; Csiszar A; Losonczy G; Valcarcel-Ares MN; Sonntag WE; Csiszar A
J Gerontol A Biol Sci Med Sci; 2013 Aug; 68(8):877-91. PubMed ID: 23239824
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of DICER1 induced by the upregulation of GATA1 contributes to the proliferation and apoptosis of leukemia cells.
Bai Y; Qiu GR; Zhou F; Gong LY; Gao F; Sun KL
Int J Oncol; 2013 Apr; 42(4):1317-24. PubMed ID: 23426981
[TBL] [Abstract][Full Text] [Related]
20. Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness.
Ramírez-Moya J; Wert-Lamas L; Riesco-Eizaguirre G; Santisteban P
Oncogene; 2019 Jul; 38(27):5486-5499. PubMed ID: 30967628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
